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ABSTRACT 
PURPOSE This study was designed to determine whether the use of advanced features of 
an electronic medical record in a primary care setting could improve the process of 
delivering diabetes care in such a way as to produce improvements in diabetic outcome 
measures in adult type II diabetic patients. 
 
METHODS The study was a Retrospective Cohort Study conducted in primary care clinics 
that had an established electronic medical record following 307 adult patients with type II 
diabetes over the course of two years. The clinics had similarly trained primary care 
physicians, similar patient populations, and used common diabetic care guidelines. The 
advanced EMR features used during the diabetic study included a diabetic template, 
premade laboratory requisitions, appeared consultations, flow sheets, and patient alerts. 
The dependent variables measured included the process of the delivery of diabetic care and 
the measurement of diabetic outcomes. The process of care measures were: the frequency 
of visits specific for diabetes care, ordering of HbA1c and LDL cholesterol, the 
measurement of blood pressure, and the documentation of these activities. The outcome 
measures included glycemic, lipid and blood pressure control as measured by HbA1c, LDL 
and blood pressure levels. The two independent variables of interest in the study were the 
extent to which the advanced features EMR are use by the physician and the second any 
changes noted in the outcome measures. 
 
RESULTS The demographic information for the patients in this study was sex and age as 
well as baseline HbA1c, LDL, baseline systolic blood pressures, baseline diastolic blood 
pressures, and the number of visits that each patient had during the study period. The two 
groups were seen to be similar at baseline except for age and systolic blood pressure. The 
mean age of the intervention group was four years older than the control group and the 
comparison group had more people with systolic blood pressure at target. Age and systolic 
blood pressure were therefore controlled in the analysis. There was no difference in the 
two groups of patients in terms of measurements of HbA1c but there were differences in 
the frequency of measurements of LDL and blood pressures. Patients for whom the 
template was used during at least one clinical encounter, were 1.18 times more likely to 
have their LDL measured and 1.9 times more likely to have their blood pressure measured. 
Using logistics regression analysis there was a higher proportion of patients with an LDL at 
target in the intervention group. 
 
CONCLUSIONS The meaningful use of EMRs in primary care, is possible through a process 
of maturity by design; an individualized approach looking at the needs of a given 
physician(s) and their practice(s) most likely to aid EMRs in achieving their potential.  The 
technology needs to support care by automation of clinical processes and work flow behind 
the computer screen in such a way as to not disrupt or significantly change the patient 
physician interaction and focus both of these individuals on managing meaningful clinical 
outcomes personalized to each patient.  
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CHAPTER 1: Introduction 
 
1.0 Overview of the chapter 
 
Electronic medical records are computer-based patient records detailing patient 
demographics, medical and drug history, and diagnostic and laboratory information. They 
are described as being transformative in nature, with the potential to fundamentally 
change the work, productivity and processes in community-based practices thereby 
facilitating enhanced delivery of care.  Chronic disease in general, and diabetes in particular 
present an ideal opportunity for the incorporation of health information technology into 
the provision of primary care medicine. The disease is highly prevalent in primary care 
populations, especially in Newfoundland and Labrador, is frequently associated with 
comorbid conditions, and requires multiple medications in its management. Additionally 
the effective care of a diabetic patient involves  monitoring of several measures of disease 
control such as HbA1c and low-density lipoprotein levels as well as blood pressures. All of 
these factors combined to make diabetes an opportune disease state for the study of the 
implementation of health information technology in the management chronic disease 
conditions. 
 
1.1 Introduction to the topic 
 
Diabetes mellitus is a disease condition characterized by a disruption in glucose hemostasis 
that affects approximately 23 million people in Canada and the United States and accounts 
for approximately 105 billion dollars in annual health care costs.1 Diabetic patients belong 
to one of two different disease classifications depending upon the underlying pathology.  
Type 1 diabetes, characterized by an absolute insulin deficiency, results from the 
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autoimmune destruction of the insulin-producing pancreatic beta cells, while Type 2 
diabetes, results from in a relative deficiency in insulin due to both impaired insulin 
secretion and resistance to its action, often secondary to obesity.  Ninety to ninety-five 
percent of patients with diabetes have type 2 diabetes. In addition to being a major risk 
factor for cardiovascular disease, diabetes is also the primary cause of renal failure, 
blindness and non-traumatic limb amputation worldwide.2 This is in spite of the 
availability of affordable and well-tolerated medications and the presence of evidence 
based clinical guidelines on the management of the disease. 
 
Attempts to disseminate clinical practice guidelines (CPGs) for the management of diabetes 
have increased markedly in the past twenty years.3 The motivation for this is the belief that 
CPGs can improve the quality of care by: increasing the use of evidence-based therapeutics 
to achieve identified targets; reducing harmful management strategies; and improving cost 
effectiveness. 4In spite of the wide spread dissemination, research suggests the guidelines 
are not as widely adopted as their authors might have wished.5  Cabana et al.6 attempted to 
determine why this is the case and reviewed 76 papers that investigated barriers to 
physician use of CPGs. The authors identified 293 individual barriers, which they 
subsequently divided into three broad groups: Physician knowledge, defined as a lack of 
awareness of and familiarity with the CPGs; Physician attitudes, which included a lack of 
agreement on specific guidelines, concern about whether the guidelines would work in 
actual patient populations, and skepticism about implementing GPGs into their practice; 
and Factors external to the physician, relating to the difficulty or complexity of the 
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guidelines, and a lack of resources for the implementation of the recommendations into 
their practices. 
 
The majority of care for diabetics is provided in the community primary care practice 
setting. An environment characterized by short visits, competing visit objectives, issues 
around the management of multiple patient morbidities and medications, and patient and 
physician inertia related to the management of chronic disease conditions, it suffers also 
from an inadequate information structure.7  
 
These are significant barriers to the management of diabetes, which are even more 
pronounced if an innovative approach to diabetes is applied to the management of the 
condition. In such an innovative paradigm the patient is not a passive recipient of medical 
ministrations but rather a part of a unit with the main provider serving as a resource coach 
and the patient as the principal driver of change.  Regardless of which approach is taken in 
the treatment of type 2 diabetes information management is critical. 
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1.2 Literature on the effectiveness and impact of EMRs on Diabetes 
 
1.2.1 Introduction 
 
A literature review was conducted according to the methods provided by the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2009 flow diagram.8   
 
1.2.2 Background 
 
Electronic medical records (EMRs) have been proposed as an effective health information 
management tool to improve diabetes care.9  Proponents suggest the EMR can be used to 
identify patients with diabetes, assess if the patient is due any tests or screening 
procedures, and populate flow sheets used to track goals for glycemic, lipid and blood 
pressure control. Furthermore, EMRs have also been advanced as a means to improve the 
coordination of care among members of the health care team,10 decrease the instance of 
incomplete clinical data,11 and support evidence based clinical decision-making.12 
Movement towards wide-spread adoption of EMRs has been relatively slow with the 2013 
National Physician Survey (NPS) showing exclusive use of EMRs by family physicians and 
general physicians at 64.3% and other specialists across Canada at 59.5%.  Further 
research showed that 20 percent of users were only using basic EMR features such as 
patient data and prescribing13 and only 4 to 6 percent of clinicians were utilizing full 
functionality for results management and clinical decision support.14 15  
 
Multiple uncontrolled studies have shown improvement in diabetes care temporally linked 
to EMR use, which may be over-stated given the general improvement in diabetes care over 
the past decade.16  Controlled studies show limited positive impact on out-patient diabetes 
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care17 with the principle improvement being in processes of diabetic care. Commercially 
developed EMRs do not seem to improve patient care in the primary care setting18 while 
systems developed in-house over time improve adherence to clinical guidelines.19 The 
research objective of this thesis is to determine if an EMR, configured with a locally 
developed diabetes profile and supported with clinical decision making tools, improves the 
management of patients as measured in terms of achieving three primary targets: blood 
pressure; HbA1c; and low density lipoprotein.  The study is a before and after trial in which 
each physician’s management of their diabetic patients is evaluated prior to and after the 
implementation of enhanced EMR features.  The study involves seven family physicians in 
two clinics caring for over seven hundred diabetic patients.  
1.2.3 Literature Search Strategy 
 
A search strategy was formulated to answer the clinical question of the impact of an EMR 
on the management of adult patients with type-two diabetes by family physicians in a 
primary care setting.  Particular attention was paid to randomized controlled trials, as 
these were most likely to provide valid information on the extent of the impact of the 
electronic interventions on the management of diabetes. Studies addressing the research 
question were identified through an electronic search of Pubmed/Medline, Embase, and 
Cinahl databases.  The databases were searched by using a combination of database-
specific subject headings (starting from the following Mesh Terms: computer or electronic 
or EMR and diabetes or diabetic and primary care or family medicine or family practice or 
therapy computer-assisted or electronic health records and diabetes, type /organization 
and administration or diabetes, type 2/prevention and control or diabetes, type 
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2/rehabilitation or diabetes mellitus, type 2/therapy and primary health care or family 
practice) and text-words for each domain in the search field. 
 
Furthermore the search was expanded to include hand searches of the references related of 
the most relevant articles and the 2013 Diabetes Clinical Practice Guidelines.  
 
The search was limited to English language publications from the last ten years and 
inclusion restricted to studies that described primary care physicians’ use of electronic 
medical records in community practices to manage adult type 2 diabetic patients.  The 
included studies looked at review articles, papers reporting on outcome measures and, 
research focused on both process and outcome measures.  
 
1.2.4 Exclusion and Sorting 
 
Papers were excluded if they did not describe the management of adult type 2 patients in 
primary care practices with electronic medical records. The initial screening was done by 
the author reviewing titles and abstracts and then examining the full-text versions of 
selected articles to further assess relevance of the research topic. 
 
1.2.5 Findings 
 
A total of three hundred and forty three studies were identified and the search strategy 
used to identify the relevant articles is depicted in figure form (Figure 1).  A summary of 
the relevant articles is presents in table form. (Tables 1-3). 
 
  
7 | P a g e  
 
Figure 1: PRISMA 2009 Flow Diagram 
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Table 1: Summary of Relevant Review Articles 
Title, Author, and Year Type of Paper Conclusions 
A Proposal for Electronic 
Medical Records in U.S 
Primary Care. Bates (2003) 
Position paper developed over four 
years by multiple organizations 
representing 300,000 primary care 
practitioners in the United States.  
Electronic medical records provide many 
 benefits, especially to primary care providers 
and given that such benefits are population  
wide they should be funded with  
public-private partnerships. 
Information Technology for 
Clinical Guideline 
Implementation: Perceptions 
of Multidisciplinary 
Stakeholders. Lyons (2004) 
Descriptive content analysis of 
1,500 pages of focus group 
transcripts. 
Administrators, physicians, and nurses hold 
different opinions about specific facilitators 
and barriers to information technology and 
clinical guideline use.  Such disparate 
perceptions could undermine guideline 
initiatives. 
Information Technology for 
the Treatment of Diabetes: 
Improving Outcomes and 
Controlling Costs. Wyne 
(2008) 
Review article examining the 
practical applications of HIT for 
improving the delivery of care in 
diabetics 
Implementation of information technology 
enabled diabetes management has 
demonstrated significant potential for 
improving processes of care, preventing 
development of diabetic complications, and 
generating cost savings.  It improves the 
synthesis of information, the delivery of 
knowledge, and the efficacy of 
communication, allowing for coordination 
of care across teams.  The diabetes 
registries show the most potential benefit 
for improving outcomes and reducing costs. 
The use of information 
technology to enhance 
diabetes management in 
primary care:  a literature 
review. Adaji (2008) 
A literature review Information technology can be used to 
improve diabetes care by promoting a 
productive and informative interaction 
between the patient and the care team. 
How to Successfully Select and 
Implement Electronic Health 
Records in Small Ambulatory 
Practice Settings. Lorenzi 
(2009) 
Review paper providing an 
overview from the literature of the 
perceived benefits and barriers to 
adopting HER into smaller 
practices. 
The EMR implementation experience 
depends upon a variety of factors including 
the technology, training, leadership, the 
change management process, and the 
individual character of each ambulatory 
practice environment.  Sound processes 
must support both technical and personnel-
related organizational components. 
Use of Health Information 
Technology to Advance 
Evidence-Based Care: Lessons 
from VA QUERI Program. 
Hynes (2009) 
Document analysis of 86 
implementation project abstracts 
followed up by semi-structured 
interviews with key informants 
from nine centres evaluated with 
qualitative and descriptive analysis. 
Collaboration with multiple stakeholders is 
a key factor in successful use and 
development of HIT in implementation 
research efforts and in advancing evidence-
bases practice. 
Health Information 
Technology: Integration of 
Clinical Workflow into 
Meaningful Use of Electronic 
Health records. Bowens 
(2010) 
Review of literature examining the 
role that clinical workflow plays on 
the successful implementation of 
HER in ambulatory care settings 
The integration of EMR into clinical 
workflow will require a synergy between 
multiple approaches. 
Electronic Health Records and 
Quality of Diabetes Care. 
Cebul (2011) 
Retrospective cohort of primary 
care practices of seven diverse 
health care organizations that 
publically reported achievement of 
quality standards for adults with 
Federal Policies encouraging the 
meaningful use of EHRs may improve the 
quality of diabetes care across insurance 
types. 
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diabetes between July 2007 and 
June 2010.  
Qualitative Evaluation of a 
Diabetes Electronic Decision 
Support Tool: Views of Users. 
Wan (2012) 
Qualitative study of telephone 
interviews of practitioners who had 
used an EDS tool for a minimum of 
six weeks.  The transcripts were 
coded and thematically analyses 
using NVivo software. 
The EDS tool showed promise as a way of 
summarizing information about patients’ 
diabetes state, as a reminder of required 
diabetes care and an aide to patient 
education. 
 
According to Wyne (2008), diabetes management enabled by health information technology has 
a significant potential for improving the process by which such care is delivered, thereby 
preventing the development of diabetic complications and generating system wide cost savings. 
In the literature review conducted by Adaji (2008), it was noted that information technology can 
improve productivity, and information interaction between the patient and the care team, but 
different opinions about specific facilitators and barriers to information technology adaption 
(identified by Lyons) among administrators, physicians, and nurses, suggests that this process 
may be problematic as a lack of collaboration between multiple stakeholders may lead to an 
unsuccessful HIT implementation. The success of an EMR implementation is dependent upon: the 
nature of the technology itself; the quality of training; the leadership within the group; the 
change management process; and the individual character of the practice in which the 
implementation is being undertaken (Lorenzi). Integrating the electronic medical record into the 
clinical workflow rather than structuring the delivery of care to fit the EMR is key to a successful 
implementation (Bowens) and tools that summarize information about an individual patient's 
diabetic state and remind the clinician of the requirement for diabetic care show promise in the 
management of these patients. 
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Table 2: Summary of Relevant Outcome Articles 
Title, Author, and Year Type of Paper Conclusions 
The Impact of Planned Care 
and a Diabetic Electronic 
Management System on 
Community-Based Diabetes 
Care.  Montori (2002) 
Before and after study comparing 
metabolic outcomes (including 
HbA1c, lipids and blood pressure 
values) over a twenty-four-month 
period in adult type two diabetics.  
Two hundred randomly selected 
patients were followed and a 
multivariable analysis used to 
estimate the association between 
planned care and a diabetes 
electronic management system. 
Planned care was associated with improved 
performance and metabolic outcomes in 
diabetics in the primary care setting. 
 
 
Table 3: Summary of the Process and Outcome Article 
Title, Author, and Year Type of Paper Conclusions 
Linking Guidelines to 
Electronic Health Records 
Design for Improved Chronic 
Disease Management. 
Barretto (2003) 
A case study of guideline-compliant 
treatment of hypertension in 
diabetes with reference to the 
guideline algorithm from the Texas 
Diabetic Council 
In the operation of an electronic chronic 
disease management system the 
information sourced from a common 
guideline must coordinate with the EMR 
content and should provide clear 
documentation of the clinical decisions 
taken. 
Impact of an Electronic 
Medical record on Diabetes 
Quality of Care. O’Connor 
(2005) 
Five year longitudinal study of 122 
adult type two diabetics in an EMR 
clinic and a non-EMR clinic.  
The EMR lead to an increased number of 
HbA1c and LDL tests but not to improved 
metabolic control.   
Electronic Medical records 
and Diabetes Quality of Care: 
Results from a sample of 
Family Medicine Practices. 
Crosson (2007) 
Cross-sectional analysis of baseline 
data from 50 practices participating 
in a practice improvement study 
between April 2003 and December 
2004.  A chart audit review a 
random sample of medical records 
for adherence to guidelines for 
diabetic processes of care, 
treatment, and achievement of 
intermediate outcomes. 
The use of an EMR in primary care 
practices is insufficient for insuring high-
quality diabetes care.  Effort to expand EMR 
use should focus not only on improving 
technology but also on developing methods 
for implementing and integrating this 
technology into practice reality. 
Electronic Medical records-
Assisted Design of a Cluster-
Randomized Trial to Improve 
Diabetes Care and Outcomes. 
Love (2007) 
Clustered randomized trial of 
12,675 patients comparing the 
effect of an EMR-facilitated disease 
management system against patient 
empowerment. 
EMRs facilitated rigorous CRT design 
enables fair comparisons and can be 
replicated for other conditions enhancing 
the power of translational investigations. 
Improving Diabetes Care in 
Practice Findings from the 
TRANSLATE Trial. Peterson 
(2008)  
A group-randomized controlled 
clinical trial evaluating the practical 
effectiveness of a multicomponent 
intervention in 24 practices.  The 
intervention included 
implementation of an electronic 
diabetic registry, visit reminders, 
and patient-specific physician 
alerts. 
Introduction of a multicomponent 
organizational intervention in the primary 
care setting significantly increases the 
percentage of type two diabetic patients 
achieving the recommended clinical 
outcomes. 
 
Individualized Electronic A pragmatic randomized trial A shared electronic decision-support 
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Decisions support and 
Reminders to Improve 
Diabetes Care in the 
Community: COMPLETE II 
Randomized Trial 
involving adult type two diabetics 
who are assigned to regular care or 
an intervention wing with a web 
based color-coded diabetes tracker. 
system to support the primary care of 
diabetes improves the process of care and 
some clinical markers of the quality of 
diabetes care. 
Beyond Health Information 
Technology:  Critical Factors 
Necessary for Effective 
Diabetes Disease 
Management. Ciemins (2009) 
A pre/post intervention cohort 
analysis of 495 adult patients 
selected randomly and followed for 
six years.  Two intervention phases 
were followed the first consisted of 
education and the second an EHR 
diabetes management period which 
included a diabetes registry and 
office workflow changes. 
Implementation of a specialized EMR 
combined with tailored office workflow 
process changes was associated with 
increased adherence to ADA guidelines. 
 
Impact of Electronic Health 
Record Clinical Decision 
Support on Diabetes Care: A 
Randomized Trial. O’Connor 
(2011) 
A clinical-randomized trial 
conducted from October 2006 to 
May 2007 of 2,556 patients in 11 
clinics and 41 primary care 
physicians.  Patients were 
randomized to either receive or 
not receive an EHR based clinical 
decision support system to 
improve care for patients whose 
biochemical markers were not at 
target during any office visit. 
EHR-based diabetes clinical decisions 
support significantly improved glucose 
control and some aspects of blood 
pressure control in adults with type two 
diabetes. 
Typical Electronic Health 
Record Use in Primary Care 
Practices and the Quality of 
Diabetes Care. Crosson 
(2012) 
Group-randomized quality 
improvement trial with 798 
patients, which used hierarchical 
linear models to examine the 
relationship between EHR use 
adherence to evidence-based 
diabetes, care guidelines, and 
hierarchical logistic models to 
compare rates of improvement over 
three years. 
Consistent use of an EHR over three years 
does not ensure successful use for 
improving the quality of diabetes care. 
 
 
The use of an EMR in primary care practices even over a significant period of time is insufficient 
on its own to ensure high-quality diabetic care (Crosson) and may simply lead to the ordering of 
an increased number of hemoglobin A-1C and LDL tests with no measurable improvement in 
metabolic control (O’Connor).  Increased adherence with the diabetic guidelines are seen when 
fully functional and specialized EMRs are combined with office workflow process changes 
(Ciemins) and multicomponent organizational intervention in primary care clinics increase the 
percentage of type II diabetic patients at the recommended clinical outcomes (Peterson).  
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1.3 Literature on Health Information Technology (HIT) in the Management of Adult Type Two 
Diabetics by Family Physicians in Primary Care 
 
1.3.1 What is HIT 
 
Over the last twenty years primary care has been advanced as both an orientating philosophy for 
the provision of community based medical services and as an actionable strategy for promoting 
and protecting the health of individuals in a cost effective manner.  A study performed by 
Macinko and colleagues, which examined the impact of primary care systems in eighteen OECD 
countries from 1970-1998, demonstrated that nations with strong primary care systems had 
lower all-cause mortality, lower all-cause premature mortality and, lower all-cause mortality 
from selected chronic diseases.20 In the United States of America the supply of primary care 
physicians has been showed to be associated with better health outcomes which include: lower 
all-cause mortality21; lower rates of cancer, heart disease and infant mortality22; and longer life 
expectancy23.  The United Kingdom showed higher numbers of primary care physicians are 
associated with better self-reported health24 and less obesity25. While Canadian studies have 
demonstrated how a larger supply of family physicians has been associated with earlier detection 
of breast cancer26, more recommended newborn and preventive care visits for children,27 and 
improved population health outcomes at a provincial level.28 
 
Primary care was defined by the American Institute for Medicine in the late nineties as, “the 
provision of integrated, accessible health care services by clinicians accountable for addressing 
most personal health care needs, as developing a sustained partnership with patients, and 
practicing in the context of family and community.”29 This mirrored the definition advanced by 
Barbara Starfield that primary care is “that level of a health care service system that provides 
entry into the system for all new needs and problems, provides person-focused (not disease-
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orientated) care over time, provides care for all but very uncommon or unusual conditions, and 
co-ordinates or integrates care provided elsewhere by others”.30  The Canadian Institutes for 
Health Research (CIHR) has championed the term “community-based primary health care” 
(CBPHC) as a “ broad range of primary prevention and primary care services within the 
community, including health promotion and disease prevention; the diagnosis, treatment and 
management of chronic and episodic illness; rehabilitation support; and end of life care.”31 
From 2000 to 2006 the province of Newfoundland and Labrador received 9.7 million dollars 
from the Federal government to aid in primary health care renewal.  Funding was used, in part, to 
create networks of nine primary health care teams in order to provide a continuum of services 
including the treatment and management of chronic diseases.  With the end of Federal funding in 
2006, and the province’s decision not to continue funding, the office of Primary Health Care 
closed. According to a report from the Auditor General of Newfoundland and Labrador, “As a 
result (of the closure of the office of Primary Health Care) the Province has not progressed to the 
level at which it should be with regard to the management and control of chronic disease.”32 The 
report continues to state that the elimination of the office resulted meant that the Department of 
Health was no longer providing support for the diabetes visits flow sheet to primary care 
providers and that funding for the Provincial Chronic Disease Collaborative Database which 
collected and reported the data contained in these sheets also ceased. According to the auditor 
this means that the Canadian Diabetes Association’s estimates of the burden of diabetes in 
Newfoundland and Labrador has not captured the true cost of the condition due to incomplete 
data. (Table 4). 
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Table 4: The Burden of Diabetes in Newfoundland and Labrador 
Key Statistics 2010 2020 
Estimated diabetes 
prevalence (%) 
9.3 14.4 
Estimated number of 
people with diabetes 
47,000 73,000 
Estimated cost of 
diabetes 
$254 million $322 million 
Estimated diabetes 
prevalence increase 
(%) 
56% increase from 2010-
2020 
 
Estimated cost increase 
(%) 
27% increase from 2010-
2020 
 
 
 
Central to the delivery of primary care is the family physician; who during the provision of care, 
manages information from a multitude of sources, integrates it into a system of biomedical 
knowledge, and decides in cooperation with patients on a therapeutic course of action. (Figure 2). 
Historically this has been accomplished with paper-based systems due to their ease of use, low 
cost and widespread acceptance.  The challenge with a paper-based office is that data are stored 
in a passive format which prevents the automatic triggering of clinical decision support tools and 
impedes decision-making.  This process becomes significantly more involved when the family 
physician is managing a chronic disease condition such as diabetes which has a high prevalence, 
is frequently associated with comorbid conditions, requires multiple medications, involves 
monitoring several biochemical markers, and intersects with multiple different providers.  All of 
these factors make diabetes an opportune disease state for the implementation of health 
information technology (HIT). 
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Figure 2: The Flow of information in primary care adapted from Ebell and Frame33 
 
 
HIT has been defined by the American Government Accountable Office (GAO) as “technology used 
to collect, store, retrieve, and transfer clinical, administrative, and financial health information 
electronically.”  In practical terms this technology is used to provide documentation in medical 
records, order labs and diagnostic imagery tests, generate prescriptions, schedule appointments 
and follow-up, billing, messaging, providing patient resources and analysis and reporting.  HIT 
comprises a number of processes and systems with varying degrees of interoperability which 
include Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Personal Health 
Records (PHRs), Computerized Physician Order Entry systems (CPOEs), Clinical Decision Support 
systems (CDS), and electronic prescribing systems (e-prescribing).  
 
Advances in HIT provide the clinician with expert, timely, and meaningful data about patients 
and populations and have resulted in new opportunities for the design and delivery of healthcare.  
HIT has been used to create diabetic registries which providers can use to perform clinical 
audits.34 Patients can track their blood glucose and blood pressures electronically download 
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those results into their computers and share them electronically with their primary care 
provider.35 E-mail communications between patients, physicians and other care providers have 
facilitated interactive feedback based upon uploaded results and patients have been provided 
opportunity to view selected areas of their EMR all to produce better diabetic management.36 37 
 
The principle difference between HIT systems is the level of information sharing and the 
purported use for this information.  An EHR is a secure and private lifetime record of health and 
care history available electronically to authorized health care providers.38  In a Canadian context 
the EHR is to be operated by provincial governments as a higher-level system that pulls 
information from other systems such as EMR, PHR, and e-prescribing networks to allow for 
monitoring of health outcomes and provide a pan Canadian patient record.  In contrast an EMR is 
a provider-centric tool that focuses on physician specific information.  It is configured to reflect 
the needs of the individual physician or a group of physicians who are providing direct patient 
care and as such it will contain a record of every patient encounter.39 The EMR has a central role 
in HIT as it is the principle system used by primary care providers and may interface directly 
with the EHR providing population based information or indirectly through other systems such 
as laboratory and diagnostic imagery ordering systems, pharmacy networks and provincial 
billing systems. The configurability of the EMR allows for the sequencing of activities during 
clinical encounters to improve the process by which care is delivered which is a perquisite to 
improving patient outcomes in chronic disease states. 
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1.3.2 Meaningful integration of electronic medical records into clinical workflow in the 
management of diabetic patients 
 
The extent to which HIT is incorporated in a meaningful way into the management of the adult 
patient with type two diabetes can be conceptualizes in terms of both process measures and 
outcome measures.  A process measure indicate how care was delivered and includes any 
diagnostic or therapeutic interventions while outcome measures are used to indicate the status 
of a patient at the end of an episode of care.40 A literature review conducted in 2008 by Adaji et al 
41 and published in Informatics in Primary Care identified 444 articles of which 29 were used in 
the paper (25 that satisfied the inclusion and exclusion criteria and 4 which were drawn from the 
references). Those authors found HIT lead to improved process measures such as increased 
ordering of tests for biochemical markers,42 increased number of foot43 and eye examinations44, 
increased immunizations45, and increased prescriptions for ACE inhibitors and Statins46.  (Table 
5)  
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Table 5: Impact on Process Mearues on Diabetic Care (Adapted by Adajj) 
Process Measure Clinical Decision 
Support 
(access to expertise) 
Clinical 
Information 
System 
(access to data) 
Delivery System 
Design 
(new design) 
Self 
Management 
support 
(access to patient 
tools) 
Foot check Meigs (2003) 
Statistically significant 
improvement 
East (2003) 
Statistically significant 
improvement 
Montori (2002) 
Statistically significant 
improvement 
Smith (1998) 
Statistically significant 
improvement 
  
Eye check Meigs (2003) 
Non-statistically 
significant 
improvement 
Sequist (2005) 
No improvement 
Montori (2002) 
Statistically significant 
improvement 
Branger (1999) 
Non-statistically 
significant 
improvement 
 
Immunizations  East (2003) 
Statistically significant 
improvement 
Montori (2002) 
Statistically significant 
improvement 
  
Nutritional 
advise and 
change 
 Montori 
(2002) 
Statistically significant 
improvement 
 Glasgow (2003) 
Statistically significant 
improvement 
Smoking 
cessation advise 
 Montori 
(2002) 
Statistically significant 
improvement 
 Glasgow 
(2003) 
Statistically significant 
improvement 
Physical activity 
advise 
Kim (2006) 
Statistically significant 
improvement 
Montori 
(2002) 
Statistically significant 
improvement 
 McKay (2001) 
Non-statistically 
significant 
improvement 
Kim (2006) 
Statistically significant 
improvement 
Medications Sequist (2005) 
No improvement 
   
 
 
Outcome measures, specifically HbA1C and lipid levels, showed mixed results with some studies 
showing no improvement47  while others showed statistically significant improvements.48 (Table 
6). 
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Table 6: Impact on Outcome Measures on Diabetic Care (Adapted by Adaj) 
Outcome 
Measure 
Clinical Decision 
Support 
(Access to expertise) 
Clinical 
Information 
System 
(Access to data) 
Delivery 
System Design 
(New design) 
Self 
Management 
support 
(Access to patient 
tools) 
HbA1c Smith (2004) 
Statistically significant 
improvement 
Meigs (2003) 
No statistically 
significant 
improvement 
O’Connor (2005) 
No improvement 
Levetan (2002) 
Statistically significant 
improvement 
Kim (2006) 
No statistically 
significant 
improvement 
McMahon 
(2005) 
Statistically 
significant 
improvement 
Branger (1999) 
Statistically 
significant 
improvement 
Smith (2005) 
Statistically 
significant 
improvement 
McMahon 
(2005) 
Statistically 
significant 
improvement 
Glasgow (2003) 
No statistically 
significant 
improvement 
Lee (2007) 
Statistically 
significant 
improvement 
Bond (2007) 
Statistically 
significant 
improvement 
Kwon (2004) 
Statistically 
significant 
improvement 
Kim (2006) 
No statistically 
significant 
improvement 
Harno (2006) 
Statistically 
significant 
improvement 
Smith (2005) 
Statistically 
significant 
improvement 
LDL-cholesterol Meigs (2003) 
Statistically significant 
improvement 
O’Connor (2005) 
No improvement 
 McMahon 
(2005) 
No improvement 
McMahon 
(2005) 
No improvement 
Glasgow (2003) 
Statistically 
significant 
improvement 
Harno (2006) 
Statistically 
significant 
improvement 
HDL-cholesterol   McMahon 
(2005) 
Statistically 
significant 
improvement 
McMahon 
(2005) 
Statistically 
significant 
improvement 
Glasgow (2003) 
Bond (2007) 
Statistically 
significant 
improvement 
Kwon (2004) 
Statistically 
significant 
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improvement 
Total- 
Cholesterol 
   Glasgow (2003) 
Statistically 
significant 
improvement 
Lee (2007) 
Statistically 
significant 
improvement 
Bond (2007) 
Statistically 
significant 
improvement 
Harno (2006) 
Statistically 
significant 
improvement 
Triglycerides   McMahon 
(2005) 
Statistically 
significant 
improvement 
McMahon 
(2005) 
Statistically 
significant 
improvement 
Glasgow (2003) 
Statistically 
significant 
improvement 
Kwon (2004) 
Statistically 
significant 
improvement 
Harno (2006) 
Statistically 
significant 
improvement 
Blood pressure Meigs (2003) 
No improvement 
 McMahon 
(2005) 
Statistically 
significant 
improvement 
McMahon 
(2005) 
Statistically 
significant 
improvement 
Bond (2007) 
Statistically 
significant 
improvement 
Harno (2006) 
Statistically 
significant 
improvement 
 
Body weight    Bond (2007) 
Statistically 
significant 
improvement 
Blood glucose Lee (2007) 
Statistically significant 
improvement 
Kim (2006) 
No statistically 
significant 
improvement 
 Lee (2007) 
Statistically 
significant 
improvement 
Kim (2006) 
No statistically 
significant 
improvement 
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The literature review by Adaji et al examined the impact from HIT systems which provided 
clinical decision support in the form of access to expertise, clinical information systems which 
provided patient data, delivery system designs which made changes to the means in which 
diabetes care was delivered, and self-management support which empowered patients with the 
information required to manage their diabetes.  By the authors own admission their paper was 
limited in that there was considerable variability in the methods used in the studies and the 
papers considered were not scrutinized for methodological quality.  That notwithstanding the 
findings suggest that HIT can improve patient self-management, enhance the delivery of diabetes 
care, and support clinical decision making with corresponding improvements in process and 
outcome measures. 
 
The meaningful integration of an EMR into the clinical workflow of the primary care provider is a 
change management exercise and requires attention to the potential benefits and barriers of an 
EMR implementation. (Table 7)  
Table 7: Potential Benefits and Barriers of EMR use in Diabetes Management49 
 
Potential Benefits Potential Barriers 
Increased quality of healthcare Initial cost 
Reduction in medication errors Physician resistance 
Improvement in patient outcomes Lack of funding 
Reduction in health disparities Fear of change 
Cost savings Privacy and security 
Improved patient safety Concerns of return on investment 
Augmented chronic disease management Lack of vision 
 
While cost, funding, and concerns over return on investment (which includes physician time) are 
important to overcome, meaningful use of the EMR in diabetes management ultimately rests on 
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the removal of physician resistance.50 Research has shown that physicians heavily weigh the 
potential effects of EMR on routine workflow.51 (Table 8). 
Table 8: Tasks Associated with Clinical Work-Flow52 
 
Administrative Tasks Clinical Tasks 
Scheduling appointments Medical treatment 
Documenting patient information Documentation of history 
Accessing patient records Examination and assessment of patient 
Processing billing and claims Develop treatment plan 
communication Patient education 
 Prescription of medication 
 Order entry 
 Arrange referrals and clinic follow-up 
 
As noted by Leu et al., “Understanding the full clinical context for HIT to the level of the task, 
resources, and workflow is a necessary prerequisite for successful adoption of HIT and 
measurement of its diffusion.”53  This is a complex task and consequently the movement to 
meaningful EMR implementation in the management of diabetes in the primary care setting has 
not been realized. In general terms an EMR implementation can be conceptualized as five step 
process requiring the physicians to, at each stage, identify and correct any issues that may 
impede workflow process issues before, during and after the implementation. (Figure 3)54 
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Figure 3: Phases of an EMR Implementation55 
 
 
The post implementation phase is particularly important in relation to the meaningful use of the 
EMR.  It is a process of maturation, after the initial shift in work flow, where physicians use EMR 
data in practice based population health management activities and/or use a specific bundle of 
EMR functionalities for chronic disease management.  Functionalities which include the creation 
of patient registries for all diabetic patients, a systematic recall process for those patients, 
diabetes focused visits, clinical flow sheets to display key outcome measures in a longitudinal 
fashion to highlight trends, and links to expert management sites.  According to the Alberta POSP 
Benefits Survey conducted in 2012, 86% of physicians enrolled in the Alberta EMR program 
reported that these functionalities improved their ability to manage patients with chronic 
diseases.  
1.4 Summary 
 
The implementation of information technology enabled diabetes management has demonstrated 
significant potential for improving the processes of care, preventing the development of diabetic 
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•Process of understanding both the practice needs and the capabilities of the EMR systems under 
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Phase 3
•Preimplementation
•Process of communicating with the involved parties to redesign workflows, establish a project plan 
and arrange for training.
Phase 4
•Implementation
•Process of making and managing change which involves radid implementation and extensive 
support
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•Post implementation
•Process of continious updating, training, and evaluation 
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complications, and generating cost savings to the health care system. It has been seen to improve 
the synthesis of information, the delivery of knowledge, and the efficacy of communication; 
thereby allowing for coordination of care across teams. The physicians, nurses, and administers 
members of these teams hold different opinions about specific facilitators and barriers to 
information technology and clinical guideline use and such disparaging perceptions can 
undermine EMR initiatives. As such successful EMR implementation in guideline based chronic 
disease management depends upon a variety of factors including the technology, training, 
leadership, change management process, and the individual character of each ambulatory 
practice environment. Sound change management processes must support both technical and 
personal related organizational components. It is only through a multicomponent organizational 
intervention with repeated interventions that an EMR in the primary care setting can significant 
increase the percentage of type II diabetic patients achieving the recommended clinical 
outcomes. 
 
The use of an EMR in primary care practices, an environment characterized by short visits, 
competing visit objectives, issues around the management of multiple patient morbidities and 
medications, and patient and physician inertia related to the management of chronic disease, is 
insufficient in and of itself for ensuring high-quality diabetes care. As such efforts to expand EMR 
use in diabetic management should focus not only on improving technology but also on 
developing methods for implementing and integrating this technology into practice reality. Steps 
as simple as using the EMR to produce diabetes registries show significant potential benefit for 
improving outcomes and reducing costs. Plan care, associated with improved performance and 
metabolic outcomes in diabetes in the primary care setting, is easier to deliver to identifiable 
patient populations. The EMR increase in the number of HbA1c and LDL tests ordered, but not 
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linked to improve metabolic control, can be mitigated by simple flow charts graphically 
representing trends in these values which support improved process of care by drawing the 
attention of both physician and patient to values that are not at desired target .  Thereby 
facilitating decision-making in an individual patient’s care plan to alter medications, improve 
clinical markers, and the quality of diabetic care.  
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CHAPTER 2: Development of the Intervention 
 
2.0 Overview of the chapter 
 
The quality of outpatient diabetic care falls short of evidence-based care recommendations56, and 
various strategies have been suggested to improve diabetic care. EMRs have been proposed as a 
potentially effective information management tool for improving diabetes care57, and an Institute 
of Medicine report has identified key features of EMRs that may lead to better care.58 Current 
outpatient EMRs can be used to identify patients with diabetes, assess whether the patient is due 
for recommended tests or screening procedures, and determine whether the patient has or has 
not achieved evidence-based clinical goals for glycemic control, lipid control, and blood pressure 
control. 
 
Current diabetes care, in the primary care setting, is characterized by high rates of clinical inertia, 
defined as a failure to intensify treatments in patients who have not achieved evidence-based 
clinical goals. Rates of clinical inertia in diabetes visits exceed 50%59 and EMR technology seems 
well-suited to reducing this problem thereby improving care. 
 
2.1 Burden of Diabetes 
 
The expenditures for the Newfoundland and Labrador Department of Health and Community 
services for the 2010 fiscal year totaled $2.5 billion, which represented a $900 million dollar or 
56% increase over the health costs for the fiscal year 2005.60 While some of the increase can be 
attributed to the inflation relating to the cost of services and supplies, the bulk of the increase is a 
function of an ageing population and an increasing prevalence of chronic disease.  The province 
has a significant issue with the prevalence of diabetes and the increasing health care costs 
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relating to diabetes as evident from information provided by the National Diabetes Surveillance 
System (NDSS) and the Canadian Diabetes Association (CDA).   
 
2.1.1 Prevalence of diabetes in Newfoundland and Labrador 
 
According to these organizations Newfoundland and Labrador has the highest rate of diabetes of 
any jurisdiction in Canada at 9.3% of the population in 2010, which cost the province $254 
million.  The NDSS calculate the prevalence of the condition and estimated health care costs 
based upon the Medical Care Plan (MCP) figures from fee-for-service claims and hospital files 
which does not capture the information from the salaried primary care physicians who constitute 
a third of the physician work force.  Additionally the statistics for the aboriginal peoples, a 
population known to have increased incidence of diabetes, are also not tracked.  Subsequently 
the prevalence and cost of diabetes are understated.  
 
2.1.2 Prevalence of diabetes in Central Newfoundland 
 
Within the Central regional integrated healthcare authority, which serves a total population 
94,104 people, the prevalence of diabetes is listed at 11%.61 For the practices under study, which 
provide primary health care services to 6475 patients, the number of patients listed as having 
diabetes is 935 persons, which represents 14.4 % of the patient population. 
 
2.2 Overview of EMR usage in Newfoundland and Labrador 
 
The province of Newfoundland and Labrador is substantially behind other Canadian jurisdictions 
in EMR use in part because it has no financial assistance or change management services for 
physicians looking to implement EMRs into their practices. Provincial involvement in EMR 
deployment has been limited to a pilot project completed in the Eastern Health Care Authority 
almost a decade ago.  The now defunct Office of Primary Health Care (OPHC) in partnership with 
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four other organizations {the Newfoundland and Labrador Medical Association (NLMA), the 
Memorial University of Newfoundland Family Practice Unit (MUNFPU), The Newfoundland Drive 
Medical Clinic, and The Newfoundland and Labrador Centre for Health Information (NLCHI)} 
collaborated on the production of this EMR demonstration project.   
 
Funded by Canada Health Infoway and located within the Eastern Health Care Authority the 
demonstration project consisted of a four site EMR implementation conducted in the three 
academic family medicine clinics operated by MUN and one community clinic, which was also 
involved in teaching. 62  The number of strategic partners in the demonstration project has not 
been equaled in any subsequent EMR implementation and the legacy of this project had been to 
share lessons learned with physicians interested in an EMR through a peer-to-peer network. The 
success of that network was significantly limited by the absence of any financial support to EMR 
pioneers in the province and the formal peer-to-peer network has closed due to a discontinuation 
of its funding. The current number of EMR instillations around the province is a best guess and is 
listed in the following table (Table 9). 
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Table 9: EMR Installations in Newfoundland and Labrador 
 Western 
RHA 
Labrador-
Grenfell 
RHA 
Central 
RHA 
Eastern RHA Total 
Practicing 
Physicians 
129 53 146 724 1052 
Using EMR 6 0 14 44 64 
Wolf 0 0 0 27 
(Demonstration 
site) 
27 
Nightingale 6 0 14 16 34 
Other 0 0 0 1 1 
 
 
2.3 Selection deployment and maturity of the EMR in Central Newfoundland 
 
In July 2008 six family physicians from three separate clinics relocated their practices to a newly 
renovated facility complete with the largest privately funded electronic medical record 
implementation in the province of Newfoundland and Labrador and located in the Central Health 
Care Authority. The decision to transition from a paper-based system to an EMR was driven by 
practical space and staffing considerations and was informed by the work done with the 
provincial EMR demonstration project. 
2.3.1 EMR Implementation 
 
The Central Newfoundland EMR implementation was influenced by a number of factors 
including: the character of the technology; nature of training required to deploy it; organizational 
leadership; the change management process; and character of the practice environment.63  The 
EMR demonstration project in Eastern Health was a larger practice setting implementation and 
the difference in scale between it and the Central Health experience is both real and important.  
The NLCHI was able to provide the Eastern Health demonstration project with a list of approved 
vendors whose set technical, data, and messaging standards that were consistent with the 
province’s HIT vision.  The presence of dedicated IT personnel in the collaborating health care 
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authority meant that an EMR solution with large servers installed in Eastern Health’s data centre 
was possible. Involvement of multiple levels of leadership meant interfaces that accessed 
provincial laboratory and diagnostic were quickly provided.  The change management process 
was overseen by a dedicated and trained team, the cost of the system was covered by an external 
agency and the bulk of the clinical practices were remunerated in such a way that clinical 
slowdowns had less of a finical impact.  This is in contrast to the Central experience where the 
absence of funding, meaningful engagement by agencies (other than NLCHI) and the clinical 
volumes required a very different implementation strategy. 
 
Generally, successful EMR implementation can be conceptualized as consisting of several phases: 
decision; selection; pre-implementation; implementation and post-implementation.  Central to 
the implementation process is a structures approach to transitioning individuals and 
organizations from a current state to a desired future state.64 Such a change management 
strategy is subjected to less resistance in smaller organizations as there is a tendency within such 
groups to seek steady state equilibrium.65 This was the principal advantage of the Central 
Newfoundland EMR implementation.  The driving vision behind the physician’s decision to 
transition from paper charts to an EMR was to, improve patient care through more efficient 
access to electronic records leading to improve office efficiencies, was developed in a very short 
period of time.  The close working relationships between the original group of physicians 
shortened the process of identifying champions and gaining “buy in” while the previous work 
done on the demonstration project meant that the collection of information on vendors, detailing 
of financial issues, analysis of work flows and understanding the benefits were completed in 
short order.  Lessons learned by the NLCHI and communicated to the central physician group 
lead to an appreciation of the need to hire a dedicated IT professional during the pre-
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implementation phase.  In addition to providing technical expertise this position also had the 
responsibility to communicate with the physicians, office staff, and practice manager on the 
redesign of the workflow and conduct of training.  The implementation phase was largely 
accomplished with the assistance of the vendor with ongoing support provided by the local 
dedicated support person.   
 
2.3.2 EMR Selection 
 
At the end of this process the electronic medical record selected was the Nightingale EMR. This 
product was chosen because of its perceived ease-of-use, ability to integrate clinical workflow, 
cost savings resulting from decreased office staff, scalability, and overall affordability. The EMR is 
an internet-based application service provider. The application architecture uses a 128 bit SSL 
encryption and off-site data storage for the secure storage of patient information. The EMR uses 
the JavaScript programming language with the Google Web toolkit, which is fairly standard for 
Internet-based products. HTML 5/CSS3 is the markup language employed by the Nightingale 
EMR to code for the formatting of the products layout. 
 
2.3.3 EMR Maturity 
 
The post implementation phase of the EMR in Central Newfoundland was largely limited to the 
support of basic EMR usage focused on recordkeeping and clinical processes. This differed 
considerably from the work that was done and continues to be done in jurisdiction such as 
Alberta, British Columbia, Manitoba and Ontario. A white paper prepared by Canada’s Health 
Informatics Association titled Canadian EMR Adoption and Maturity Model summarized the EMR 
adoption models used in these four jurisdictions and produced a common Canadian EMR 
Adoption and Maturity Model which can be used to track the physician use of EMR to impact 
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clinical outcomes.  The resultant common adoption model, suggested by the COACH’s Canadian 
EMR adoption model, focused on three separate measures: functionality which includes the 
usefulness of tools for a particular clinical environment; breadth representing number of users, 
patients, and units, for a given product; and outcomes capturing improvements in patient health.  
(Figure 4). 
Figure 4: Common Adoption Model 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
The white paper went on to build upon commonalities identified across the four jurisdictions to 
provide a six level model of EMR adoption and maturity.  This model portrays the advancement 
of EMR maturity as physician’s progress through the respective levels (Table 10). 
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Table 10: The Canadian EMR Adoption and Maturity Model 
EMR Level  
progression 
EMR Adoption  
Level 
Description 
Serial 0  paper based Paper is the dominant means of storing, 
accessing, and exchanging information 
Serial 1  basic electronic  
record keeping 
EMR available with basic use for practice 
management streamlining of foundational clinical 
efficiency such as encounter documentation, 
prescription creation and renewal, lab ordering 
and scanning. 
Serial 2  clinical 
processes 
Establishes clinical processes with decision-
making support at the individual patient level, 
standardization of data coding and fully 
structured workflow practices. 
Serial 3  Advanced disease 
management 
Enhanced delivery and support of care from 
automated clinical workflow and process 
including a focus on outcomes to manage 
complications and on advanced tracking for 
treatment adherence. 
 
Iterative 4  Integrated care Supports adherence to optimal standards of care 
across and between care teams planning and 
reporting at the jurisdictional level through 
integration and exchange of information at the 
community and regional levels. 
Iterative 5  population impact Profiles (based on risk or conditions) sub-
populations; measures process and outcomes; 
provides performance feedback; supports 
regional health policy planning and reporting at 
the jurisdictional level. 
 
2.4 Tool development 
 
The Nightingale electronic medical record does have a chronic disease management module 
(CDM) that allows the product to be used to positively impact on entire populations of patients 
facilitating advanced disease management. In some jurisdictions diabetes management is guided 
by this CDM. Unfortunately the Nightingale implementation in the province of Newfoundland and 
Labrador is substantially smaller than in other jurisdictions and in the absence of a coordinated 
provincial EMR strategy the CDM functionality has not been engaged. As a result advanced 
disease management using this electronic medical record had to employ existing features 
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contained within the system to better organize the process of delivering diabetic care and 
attempt to improve outcome measures. A survey of the EMR usage by the seven physicians being 
studied indicated that they had some experience with the use of templates, premade laboratory 
requisitions, prepared consultations, flow sheets, and patient alerts. Subsequently each one of 
these functionalities was incorporated into the diabetic patient management tool, which 
constituted the intervention in this study, and was designed to improve the process of delivering 
diabetic care. 
 
At the beginning of the study all of the patients with a diagnosis of diabetes identified by the ICD-
9 code 0250 had a flowchart added to their cumulative patient profile. The purpose of the 
flowchart was to collect information from the diabetic clinical encounters and present that 
information in a meaningful way to allow the physician to track individual patient’s HbA1c, LDL, 
and blood pressure values. The tool was developed so that the physicians began their clinical 
encounters in the usual manner.  Once they opened a clinical encounter within the EMR they had 
opportunity to click on a profile button which allowed them to load a prepared diabetic visits 
note that automatically imported the diagnosis, prepared consultation letters, and clinical plan 
notes. During the clinical encounter the physicians had opportunity to use a template of care that 
guided the encounter and documented lab values, clinical examination, and education provided 
in a number of searchable fields that allowed for the tracking of care provided and populated the 
diabetic flow sheet.  
2.5 Deployment of the IT solution  
 
Upon completion of the configuration of all of the advanced EMR features to be used in the 
processes of delivering diabetic care in this study was completed, a six-month beta-test was 
conducted. During this period the diabetes management tool was used not by the IT personnel 
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who configured it but rather a clinician providing care to diabetic patients. Based upon the 
feedback some minor changes were made to the layout but no substantial changes to the tool 
were required. A seven page full-color double-sided professionally printed and bound “how to” 
manual was produced detailing an 11 point process to use all of the features of the study 
intervention (appendix 1).  Each of the participating physicians was provided a copy of this 
documentation during a one hour one-on-one educational process with a dedicated and 
knowledgeable IT professional. Each physician was also made aware during these educational 
sessions that at any time should they have any questions on how to use the tool that the IT 
support personnel would be available to answer these questions. One month after the initial 
education session each physician was approached by the IT support personnel and offered an 
additional educational session. 
 
2.6 Summary of the intervention 
 
The intervention was characterized by the implementation of an advanced disease management 
tool to transform the provider’s approach to managing diabetic patients in the family practice 
clinic setting. The EMR was customized to: identify all patients with diabetes; provide structured 
diabetic visit notes; prepared consultation letters; standardized laboratory requisitions; and 
populate diabetic flow sheets. The flow sheets were a key component to the intervention as they 
had been shown, in the past, to improve adherence to guidelines when it comes to assessing and 
treating diabetes.   
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CHAPTER 3: Evaluation of the Intervention 
 
3.1 Introduction 
 
This study was designed to determine whether the use of advanced features of an electronic 
medical record in a primary care setting improved the process of delivering diabetic care 
(frequency of visits, frequency of tests ordered, and documentation of critical results) and also 
produced improvements in diabetic outcome measures (HbA1c, low-density lipoprotein, and 
blood pressure values) in adult type two diabetic patients. 
 
3.2 Setting 
 
The study was conducted in primary care clinics that had established electronic medical records. 
The clinics were community-based and contained only family physicians with no on-site allied 
healthcare providers (regional diabetic clinics were available on a referral basis) and were 
teaching sites affiliated with the family medicine program of Memorial University of 
Newfoundland. Both of the EMR clinics were relatively small, with a stable staff of 3 to 4 
physicians and were leaders in the province of Newfoundland and Labrador in the adoption and 
use of electronic medical records. The community in which the clinics were embedded was 
classified as rural in nature and demographically similar to many such centres within the 
province. The EMR in the study was an Internet-based application service provider (ASP) 
developed by Nightingale Informatics Corporation. The software itself is housed on a server 
located in Markham Ontario, and backed up on a server located in Calgary Alberta, and the clinic 
computers, which store no patient information, communicate with the servers over high-speed 
Internet. The Nightingale Corporation provided regular updates to the electronic medical record 
and on-site technical support was available in both the study clinics. The cost for the EMRs were 
born by the individual physicians who, in addition to an initial purchasing and startup fee, paid 
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monthly for continued access to the EMR. The EMR clinics also participated in other diabetes-
related care improvement activities through their involvement with the Canadian Primary Care 
Sentinel and Surveillance network. This network, discussed elsewhere, provided information in 
the form of a report card to each clinician about the quality of the diabetic care that they were 
providing to their patients. Figure 5shows the timelines for the stages of EMR implementation 
just described. 
 
Figure 5: Timeline for the Central EMR  
 
The clinics involved in the study were a relatively new entity, beginning in July 2008 when the 
physicians involved, transferred their practices from four separate offices into a new facility 
complete with the largest privately funded electronic medical record implementation in the 
province of Newfoundland and Labrador. The paper charts from the previous clinics were 
initially made available to the physicians for six-month period while they transitioned fully to the 
electronic medical record at which point the charts were then stored off-site. In 2012 the original 
clinic expanded to the point where was necessarily to open up a second clinic. Physicians 
typically consulted the EMR on a computer monitor located in each clinical examination room 
Provincial EMR 
demonstration 
project
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with each patient visit.  The EMR is used to generate the clinical encounter note in the SOAP 
format, order and manage pharmaceuticals, order and manage laboratory and diagnostic imaging 
requests, and to generate consultations. Due to challenges between the clinics and the Regional 
Integrated Healthcare Authority laboratory interface could not be established with the hospital-
based meditec system and as a result the physicians involved in the studies have had to manage 
laboratory results outside of the electronic medical record.  The advanced EMR features used 
during the diabetic study included a diabetic template, premade laboratory requisitions, 
prepared consultations, flow sheets, and patient alerts. 
 
3.3 Selection of Participants 
 
To evaluate the impact of the advanced EMR features on the process and outcomes of diabetic 
care, the study focused on all adults with an established diagnosis of diabetes. The potential pool 
of participants was drawn from all of those patients having been identified in the EMR, by 
provider, as having diabetes mellitus with an ICD-9 code of 250. Each physician's roster of 
diabetic patients was then reviewed with duplicate entries deleted to generate a list of possible 
patient participants that was then subject to a further evaluation. The electronic medical record 
of every patient rostered to the participating physicians, was reviewed to determine if they truly 
were a type II diabetic over 18 years of age who attended the clinic regularly. The ICD-9 250 code 
was routinely used by the participating physicians to identify those individuals who may possibly 
have diabetes and subsequently required further investigations, or those patients who had 
impaired fasting glucose or impaired glucose tolerance and required additional management 
with regards to cardiovascular risk factors, and also used to capture those individuals who 
experienced gestational diabetes. Subsequently it was required to review each patient record 
looking at the cumulative patient profile (CPP), medication list for diabetes specific drugs, clinical 
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notes for descriptions of diabetes, and laboratory requisitions or consultation notes, to determine 
if the patient was an actual type II diabetic or file or fell into one of the other categories. This 
methodology for the identification of diabetic patients was previously evaluated with an 
estimated sensitivity of 0.91 and a specificity of 0.99 with a positive predictive value of 0.94.66 
 
A total of 935 patients out of a total patient population of 6475 were identified with the ICD-9 
code of 250 and 625 of these were excluded as either being non-diabetic, having type I diabetes 
or gestational diabetes, or having not been see during the study or having died during the study 
period.  As a result a total of 310 patients were included in the study.  
 
3.4 Dependent variables 
 
The two types of dependent variables measured included the process of the delivery of diabetic 
care and diabetic outcomes. The first type was process of care which was measured by the 
proportion of patients with the recommended number of tests performed in the year.  The 
second type was the outcome of glycemic control as measured by HbA1C and lipid control (LDL) 
in addition to BP control. These were subsequently compared to the targets identified within the 
diabetes literature. Validity of the outcomes was enhanced by the following; all of the laboratory 
tests performed during the study were performed at a single accredited clinical chemistry 
laboratory managed and operated by a regional integrated healthcare authority.  
The laboratory received its certificate of accreditation from the Institute for Quality Management 
and Healthcare based upon an assessment conducted from 12 February 2010 until 12 March 
2010 and this ISO 15189 Plus accreditation was valid for the entire study period. The LDL was 
measured using a LDLD reagent in conjunction with SYNCHRON LX systems, UniCel DxC 600/800 
systems, and SYNCHRON systems LDLD calibrator, to provide a direct qualitative determination 
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of low-density lipoprotein cholesterol in human serum.  The HbA1c was calculated using a Tosoh 
Automated Glycohemoglobin Analyzers, which used a high-performance liquid chromatography 
assay to provide a qualitative measure of the percentage of HbA1c in whole blood specimens. 
 
3.5 Independent Variables 
 
There was one independent variable of interest in this study: the extent to which the physicians 
used the advanced diabetic patient management features of the EMR.  This was measured by 
reviewing every clinical encounter for those patients identified as having diabetes during the 
study period to determine the number of diabetic visits in which the prepared diabetic care 
template was used. This was dichotomized to the patients for whom the template was used at 
least once versus not used ever. 
 
3.6 Covariates 
 
The covariates within the study include the patient's age and sex and these were obtained from 
the demographic component of the electronic medical record for each patient. 
 
3.7 Plan of Analysis 
 
The analysis was designed to test two hypotheses: (1) use of the tool is associated with the 
proportion of patients with the recommended number of tests performed in the year, and (2) use 
of the tool is associated with the change in values of HbA1c, LDL, and BP over time.  Analysis 
conducted compared the two groups of patients at baseline and provides information about; Sex, 
baseline HbA1c, baseline LDL, baseline systolic blood pressure, baseline diastolic blood pressure, 
and number of visits during study period. Chi-squared was used to test for statistical significance.  
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To control for potential confounders (age, sex, number of visits) logistic regression was 
conducted for seven outcomes.  Three process outcomes (HbA1c, LDL, and BP measured 
according to guidelines) and four physiological outcomes (HbA1c, LDL, systolic BP and diastolic 
BP achieved recommended targets).  With an additional controlled variable being the baseline of 
the relevant outcome.  
Logistic regression was conducted for each of the seven outcomes. For each of the three process 
outcomes (whether HbA1c, LDL, and BP was measured according to guidelines) the independent 
variables were Group (tool vs no tool), Age, Sex, and Number of Visits (More than 3 visits vs 3 or 
less). 
 
For the target achievement outcomes (whether HbA1c, LDL, systolic BP and diastolic BP achieved 
recommended targets) the independent variables were Group (tool vs no tool), Age, Sex, Number 
of Visits (tool vs no tool), and the baseline level of HbA1c, LDL, or Blood Pressure, depending on 
the dependent variable. 
 
3.8 Results 
 
The purpose of this research project was to determine if the advanced features of an electronic 
medical record improve the processes by which primary care physicians delivered diabetic care 
in such a way as to improve clinical outcomes. The results are represented in the following tables. 
Table 11 contains a listing of the baseline characteristics and comparison variables between the 
groups of the patients under study. The two groups are seen to be similar at baseline except for 
age and systolic blood pressure. The mean age of the intervention group was four years older 
than the comparison group and the comparison group had more people with systolic blood 
pressure at target.  These variables and others were controlled for using multivariate analysis. 
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Table 11: Baseline Characteristics and Other Group Comparison Variables 
* Based on available (non-missing) data, p value calculated using chi-squared test. 
 
 
 
 
Variable Total Population 
of Diabetic 
Patients 
N= 310 
Patients for Whom the 
Template was Used as 
least Once. 
N=108 
Patients for Whom 
the Template was 
Never Used 
N=202 
P Value* 
(Template used 
vs Template not 
used) 
 
Mean Age(Years) 
#(SD) 
65.1 (SD: 11.5) 67.9 (SD: 10.1) 63.6 (SD: 11.9) 0.001 
Sex 
#(%) 
Male 157(50.6%) 54 (50%) 103 (51%) 0.963 
Female 153 (49.4%) 54 (50%) 99 (49%) 
Baseline A1c at Target 
#(%) 
Yes 121 (39%) 37 (34.3%) 84 (43.5%) 0.147 
No 180(58.1%) 71 (65.7%) 109 (56.5%) 
Missing 9 (2.9%) 0 9  
Baseline LDL at Target 
#(%) 
Yes 155 (50%) 65 (62.5%) 90 (53.6%) 0.187 
No 117 (37.7%) 39 (37.5%) 78 (46.4%) 
Missing 38 (12.3%) 4 34  
Baseline Systolic BP at 
Target 
# (%) 
Yes 138 (44.5%) 42 (42.9%) 96 (60%) 0.011 
No 120 (38.7%) 56 (57.1%) 64 (40%) 
Missing 52 (16.8%) 10 42  
Baseline Diastolic BP 
at Target 
# (%) 
Yes 200 (64.5%) 76 (77.6%) 124 (77.5%) 0.999 
No 58 (18.7%) 22 (22.4%) 36 (22.5%) 
Missing 52 (16.8%) 10 42  
Number of Visits 
during study period 
 
More Than 3 112 (36.1%) 33 (30.6%) 79 (39.7%) 0.143 
3 or less 195 (62.9%) 75 (69.4%) 120 (60.3%) 
Missing 3 (1%) 0 3  
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Table 12 is a comparison of both the processes of delivering diabetic care and the outcomes of 
that care between the patients who had the template used and those patients who did not have 
the tool used during their clinical encounters. From this table some differences in the process of 
delivering care can be seen.  Although there were no differences in the two groups in terms of the 
measurement of HbA1c there were some differences in the frequency of the measurement of LDL 
and blood pressure.  Patients in whom the tool were used during at least one encounter however 
or 1.18 times more likely to have had their LDL measured and 1.9 times more likely to have their 
blood pressure measured that than in those patients in whom the tool was never used.  This table 
also shows that there is no significance difference in the in the proportions of people at target for 
HbA1c, LDL, or blood pressure at the end of the study.  
 
There was no relationship between the Group (Template vs no template) and the Outcome for 
Measurement of HbA1c, Proportion of patient with A1c at target, Proportion of patients with 
systolic BP at target at end of study, or the Proportion of patients with diastolic BP at target at 
end of study. 
 
However, the tool (Template use during a clinical encounter) was associated with an increased 
the likelihood that LDL would be measured, that Blood pressure would be measured, and 
increased the proportion of patients with LDL at target at the end of the study (although this 
result was borderline significant at p=0.046). 
(See Logistic Regression Tables in Appendix 2) 
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Table 12: Comparison of Patient Outcomes Between Template Used and Template Not Used 
Variable Patients for Whom 
the Tool was Used 
at least Once. 
N=108 
Patients for 
Whom the Tool 
was Never Used. 
N=202 
 
               P Value 
Interpretation 
HbA1c Measured 
according to 
Guidelines 
#(%) 
Yes 
 
108 (100%) 195 (96.5%)  
0.101 
Patients in whom the template 
was used during at least one 
encounter were no more likely to 
have HbA1c measured than in 
patients where the template was 
never used. 
 No 
 
0 (0.0%) 7 (3.5%)   
LDL Measure 
According to 
Guidelines 
#(%) 
Yes 103 (95.4%) 164 (81.2%)  
0.001 
 
 Patients in whom the template 
was used during at least one 
encounter were 1.18 times more 
likely to have LDL measured than 
in patients where the template 
was never used. 
 No 
 
5 (4.6%) 
 
38 (18.8%) 
 
  
Blood Pressure 
Measured according 
to Guidelines 
#(%) 
Yes 95 (88.0%) 151 (74.8%)  
0.010 
 
 Patients in whom the template 
was used during at least one 
encounter were 1.9 times more 
likely to have BP measured than 
in patients where the template 
was never used. 
 No 
 
13 (12.0%) 
 
51 (25.2%) 
 
  
HbA1c at target at 
end of study 
#(%) 
Yes 41 (38.0%) 93 (47.7%)  
0.130 
No difference between groups in 
proportion of people with HbA1c 
at target at end of study 
 No 67 (62.0%) 102 (52.3%)   
 Missing 0 7   
LDL  at target at end 
of study 
#(%) 
Yes 67 (65.0%) 87 (53.0%)  
0.071 
  No difference between groups in 
proportion of people with LDL at 
target at end of study 
 No 36 (35.0%) 77 (47.0%)   
 Missing 5 38   
Systolic BP at Target 
at end of study 
#(%) 
Yes 43 (45.3%) 83 (55.0%)  
0.177 
No difference between groups in 
proportion of people with 
systolic BP at target at end of 
study 
 No 52 (54.7%) 68 (45.0%)   
 Missing 13 51   
Systolic BP at Target 
at end of study 
#(%) 
Yes 70 (73.7%) 100 (66.2%)  
0.275 
No difference between groups in 
proportion of  people with  
diastolic  BP at target at end of 
study 
 No 25 (26.3%) 51 (33.8%)   
 Missing     
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CHAPTER 4:  Discussion of all sections 
 
4.1 Background 
 
This discussion will cover the three main topics of this thesis: the literature; developing the 
intervention; and the study.  This discussion contains: a background on the thesis; highlights 
of the literature in relation to the study; highlights of the literature on development of tools 
compared to the tool studies; implications for practice; recommendations for future 
research; and conclusions. 
 
The literature suggests the implementation of information enabled diabetes management 
has demonstrated the potential to improve the process of delivering care, preventing the 
development of diabetic complications, and generate cost savings.  The dynamic nature of 
the primary care practice environment represents a significant challenge to realizing these 
theoretical benefits when deploying EMRs in guideline based chronic disease management.  
Successful interventions require considerable change management process sensitive to the 
character of each ambulatory practice environment with an emphasis on planned care of the 
diabetic patient and the use of simple flow charts to graphically represent trends in values 
and to facilitate decision-making directed at improving clinical markers. 
 
Newfoundland and Labrador is the province with the highest rate of diabetes in Canada with 
9.4% of the population affected in 2010 and a cost of care of $254 million dollars annually.  
The incidence of diabetes in the Central Regional Health Care Authority and the practices 
under study were even greater at 11% and 14.4% respectively.  Using an EMR to manage 
this chronic disease occurs in the post-implementation phase of an EMR deployment when 
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the clinicians are comfortable with the basic functionalities such as encounter 
documentation, prescription creation and renewal, and ordering of lab and diagnostic 
imagery tests.  At this point EMR use has matured to the extent that clinical work flow and 
process of delivering care can shift to use of templates, premade laboratory requisitions, 
prepared consultations, flow sheets and patient alerts to manage diabetic care. 
 
The tool under study was developed so that the physicians began each clinical encounter in 
the usual manner, once they opened a diabetic patient’s chart they had opportunity to load a 
prepared diabetic encounter which automatically imported a care plan complete with 
diagnosis, prepared consultation letters and populated clinically meaningful values (HbA1c, 
LDL, BP) into searchable fields.  The tool was beta tested for a six month period and then 
launched with a one hour individual instructional session given by a dedicated HIT educator 
using a professionally produced instructional manual.  Additional sessions were available to 
each provider on request. 
 
The research question was to determine if the advanced feature of the electronic medical 
record improved the process of diabetic care in such a way as to improve clinical outcomes.  
When physicians used the diabetic tool during at least one encounter patients were 1.18 
times more likely to have their LDL measures and 1.9 times more likely to have their blood 
pressure measured.  Logistic regression analysis indicated that the intervention increased 
the proportion of patients with LDL at target at the end of the study. 
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4.2 Comparison of the Study Findings to the Literature 
 
Of the physicians understudy 42% of them used the tool at least once, obsticles to use may 
have been the perceived increase in time required to use the tool or the question of the need 
for a tool to improve the management of diabetics in their individual practices.  In 2008 
Wyne et al showed technology enabled diabetes management to have significant potential to 
improve the process of delivery of care to diabetic patients.  The use of a diabetic register, 
which identified the patients requiring focused care, was noted to be particularly important.  
Similar findings were seen in our research, in diabetic patients for whom the tool was used 
were 1.18 times more likely to have their LDL measured and 1.9 times more likely to have 
their blood pressure taken.  Increased numbers of LDL tests ordered do not necessarily lead 
to improved metabolic control (O’Connor 2005) and the use of an EMR in primary care 
practice is insufficient for ensuring high quality diabetic care (Crosson 2007).  However in 
this study the LDL targets were better met with the tool was used. 
 
The use of chronic diabetes management tools within an EMR is variable.  Implementation 
depends upon a number of factors including a change management process, which requires 
both sound technical and personal related organizational components (Lorenzi 2009) and a 
synergy between multiple approaches to encourage adoption (Bowens 2010).  Successful 
use of a specialized EMR tool for the measurement of the diabetic patient requires a 
combination of tailored office workflow process and adherence to diabetic guidelines and 
only physicians who changed their workflow to include diabetes specific visits were able to 
incorporate the EMR tool into their practice (Ciemins 2009).  Demonstrating again those 
efforts to expand EMR use should focus not only on improving technology but also on 
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developing methods for implementation and integrating technology into practice reality.  
The variability in the use of the tool in the study reported in this thesis created a naturally 
occurring experiment and allowed the comparative study to be conducted. 
 
4.3 How does the development of the tool under study compare to the tools cited in the 
literature. 
 
Electronic medical records, according to Love et al, have the potential to facilitate the design 
of large cluster randomized trials (CRTs), which are a preferred design to test interventions 
intended to change physician or patient behavior.  In his research, the Diabetes 
Improvement Group-Intervention Trial (Dig-IT), Love was able to identify and balance pre-
assigned characteristics for 12 675 patients cared for by 147 physicians in 24 practices all 
using the same EMR.  This allowed him to determine the effect of experiential interventions 
of either EMR facilitated disease management or patient empowerment with or without 
disease management.  They showed that rigorous CRT designs allowing for fair comparisons 
are possible. 
 
This study was not a CRT but rather a retrospective cohort study design to determine if the 
advanced features of an EMR in primary care clinics could improve the process and 
outcomes associated with diabetic care.  That notwithstanding, the same approach was used 
to compare patients between practices and as seen in Table 3.1 shows the two groups were 
similar on some variables.  Variables that were not similar between groups were controlled 
in the analysis using logistic regression. 
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The translate trial was a multi component organizational intervention conducted in a 
primary care setting (Peterson 2008).  The intervention targeted a number of the 
components of the chronic disease care model including implementation of an electronic 
diabetes registry; visit reminders and patient and physician specific alerts.  The electronic 
diabetes registry was either incorporated into an existing computer system or placed on a 
new computer system and a site coordinator trained in its use.  The coordinator facilitated 
pre visit planning and provided patient and physician specific reminders for each diabetic 
patient visit.  The site coordinator notified patients of scheduled visits and contacted high 
risk patients with an elevated HbA1c or SBP as well as providing monthly summaries of 
operational activity and tracked clinical measures.  This produced significant increases in 
the percentage of type two diabetic patients achieving recommended outcomes.  
 
The tool under study in this study involved the production of a diabetic registry that was 
incorporated into an existing EMR system, which included visit reminders and physician 
specific alerts.  In the absence of a site coordinator, it was the responsibility of each 
physician to identify high-risk patients and track clinical measures. 
 
Research into typical use of EMR in primary care practices comparing 16 EMR using 
practices to 26 non-EMR using practices in a group-randomized quality improvement trial 
showed that non-EMR practices were more likely to meet the targeted outcomes for HBA1c, 
LDL, and blood pressure (Crosson 2012).  The authors of this study suggested that this 
result might have stemmed from the EMR practices not investing enough in changes to work 
process and conceptualization of how this technology can be used in improving chronic 
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illness management.  Given the population management functions in commercially available 
EMR are poor and an optional component of meaningful use criteria67 this finding is not 
surprising.  As noted above the solution in part would be to assign a member of the health 
care team to maintain disease registries. 
 
The change management process with the launch of the EMR in the clinics under study was 
dedicated to basic electronic record keeping, billing processes and clinical workflow only in 
so far as it pertains to scheduling of appointments.  The study tool represented the first 
attempt at advanced disease management with a focus on process and outcomes. 
 
A five year longitudinal study of 122 adult type II diabetic patients involving EMR and non-
EMR clinics showed EMR use lead to an increased number of HbA1c and LDL tests being 
ordered but no improvement in metabolic outcomes (O’Connor 2005).  It was thought EMR 
use would assist in overcoming clinical inertia, defined as a failure to intensify treatment in 
patients who have not achieved evidence based clinical goals, which has been cited as being 
as high as 50%.  The data suggested that in spite of the increased technical sophistication of 
EMRs the link between processes of care and outcomes of care was tenuous; the level of 
HbA1c and not the frequency of ordering the tests is what predict the risk of complications 
and increased health costs. 
 
The practice tools studied in this thesis research demonstrated similar findings with a 
difference in the frequency of LDL and BP measurements but no appreciable improvement 
 
  
51 | P a g e  
 
in the proportion of people at target for HbA1c or blood pressure.  However, it did find an 
increase in one clinical outcome, better LDL control. 
 
A pre/post-intervention cohort analysis of 495 type two diabetic patients followed for six 
years showed an increased adherence to ADA guidelines (Ciemins 2009).  This study 
consisted of two intervention phases; a “Low dose” period of targeted education to patients 
and providers followed by a “high dose” diabetes management implementation phase.  The 
“high dose” intervention period was characterized by implementing an integrated EHR that 
changed the clinic’s approach to managing complex chronic conditions.  A diabetic registry 
was constructed; point of care provider alerts and a diabetic management module was 
designed, electronic forms for documentation created and patient and provider report cards 
generated.  At the study’s end patients were 3.5-6 times more likely to have been screened 
for diabetic complications, 11 times more likely to have had tests ordered, and 2-3 times 
more likely to have HbA1c, LDL, and BP controlled.  
 
The absence of “high dose” diabetic management implementation phase with physician and 
patient report cards meant that in practices considered in this author’s study that only three 
of the seven physicians used the tool for their diabetic clinical encounters.  These were part 
of the four-physician group practicing in the clinic where this author was located. 
 
4.4 Strengths and limitations 
A randomized clinical trial would have been preferred over a retrospective cohort study but 
was not possible in this real world setting.  The physician’s choice on whether or not to use 
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the tool limits this to an observational study preventing controlling for all confounders; such 
as method of physician remuneration and patients geographical factors.  The design did 
however allow for controlling for patient age, sex, and number of visits. 
 
4.5 Implications for practice 
 
The Canadian EMR adoption model advances that improvement in patient outcomes, 
measured in terms of reduced morbidity and mortality, follow naturally as a result of 
improvement in care processes.  The advanced EMR features used during the diabetic study 
were designed to improve care processes using a visit template, prepared laboratory 
requisitions, flow sheets (populated when laboratory values were entered into a defined 
field), and patient alerts. Each one of these functionalities individually represented a feature 
of the Nightingale EMR that each of the participating physicians was familiar with.  However 
this is the first time that all of those tools had been combined in the delivery of Clinical 
Practice Guideline informed care. As such the intervention may have been daunting to some 
of the clinicians and physician attitudes including skepticism about implementing GPGs into 
their practice may also have been a factor on the EMR advanced features use. 
 
The change management during the post implementation phase of the EMR in Central 
Newfoundland was focused on the support of basic EMR usage and as such it rates at EMR 
adoption level one on the six point Canadian EMR Adoption and Maturity Model.  The 
advanced EMR functionalities under study-represented maturity levels two and three 
attempting to structure workflow for diabetic patients, standardize data, and focusing on 
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meaningful clinical outcomes.  As such it may have exceeded the sophistication of EMR use 
by some of the providers.  
 
The successful use of advanced EMR features, in guideline based chronic disease 
management, requires understandable user-friendly technology, expert training, and a solid 
change management process. The change management processes must support all aspects of 
change both technical and personal.  The intervention did not have a method beyond 
education to support the physicians in making the changes required for the use of the 
advanced diabetic management tool under study. The clinic with a 75% use of the 
intervention did have an informal champion in that the author was imbedded in that clinic.  
The individual character of each ambulatory practice may have also impacted on the tools 
use, as the physicians with the higher percentage of diabetic patients in their practices were 
more likely to use the tool.  
 
It may be reasonable to conceptualize the treatment of diabetic patients in EMR clinics in 
terms of process of care delivery and clinically significant outcome measures, and that this 
treatment be delivered in a serial and progressive manner.  With the identification of a 
diabetic patient the clinician uses the basic recordkeeping functions of the EMR to document 
clinical encounters, order required labs and medications and identify the patient to a 
diabetic registry.  The diabetic registry is constructed in such a way as to book follow up 
appointments for diabetic specific visits, risk stratify patients based upon clinical outcome 
measures.  Clinical encounter templates then shift the process of care to clinical processes, 
such as, starting and titrating metformin to as close to UKPDS 38 levels as the patient will 
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tolerate and then shift pharmacological management to LDL and blood pressure control.  
The final stage in EMR use would be a shift to advanced disease management where patients 
not achieving clinical outcomes are identified for more intensive interventions and those at 
targets have their care shifted to the management of the complications of diabetes. 
 
4.6 Recommendations for future research 
 
In the absence of significant incentives and disincentives to promote the meaningful use of 
electronic medical records in smaller jurisdictions such as Newfoundland and Labrador, 
research into the characteristics of physicians and practices that would lend themselves to 
the use of advanced EMR functionality would be of merit. Audit tools to help these individual 
clinicians identify areas of their practices that would benefit from advanced EMR 
functionality would personalize such interventions. Research also conducted to identify the 
optimal number of advanced features that can be used by a clinician during any one clinical 
encounter would also be of particular value.   
 
4.7 Conclusions 
 
Electronic medical records are physician centric computer-based tools containing patient 
demographics, medical and drug history, as well as diagnostic and laboratory information 
presented in a manner that may or may not promote chronic disease management. They 
have been described as being transformative in nature, with the potential to fundamentally 
change the work, productivity, and processes of delivering care in community-based 
practices.  Chronic disease in general, and diabetes in particular present an ideal 
opportunity for health information technology to demonstrate its ability to improve the 
provision of chronic disease management in primary care medicine.  Successful EMR 
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implementation in guideline based chronic disease management is multifactorial and 
requires consideration of the technology itself, training of physicians, leadership in clinical 
excellence, and the individual character of each ambulatory practice environment. A solid 
change management process that an EMR in the primary care setting can achieve the 
maturity necessary to significantly increase the percentage of type II diabetic patients 
achieving the recommended clinical outcomes only through the introduction of a 
multicomponent intervention. 
 
Maturity emerges in EMR use is an emergent property from the three separate domains of 
functionality, breadth, and outcomes. A survey of the EMR usage by the seven physicians 
being studied indicated that they had experience with the functionalities used in the design 
of the advanced diabetic patient management tool, subsequently each one of these 
functionalities was incorporated into the intervention in this study designed to improve the 
process of delivering diabetic care. The breath of the study included seven physicians caring 
for three hundred and ten patients who met the study inclusion criteria, with three of those 
clinicians using the advanced diabetic management tool to care for a total 108 patients. 
Those patients experienced an improvement in the process of delivering diabetic care being 
1.18 times more likely to have had their LDL measured and 1.9 times more likely to have 
their blood pressure measured during the clinical encounters. In terms of improvement in 
outcome measures, using logistic regression, there was increase in the proportion of 
patients with LDL at target at the end of the study. 
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The meaningful use of EMRs in primary care, is possible through a process of maturity by 
design; an individualized approach looking at the needs of a given physician(s) and their 
practice(s) will be most likely to aid EMRs in achieving their potential.  The technology 
needs to support care by automation of clinical processes and work flow behind the 
computer screen in such a way as to not disrupt or significantly change the patient physician 
interaction and focus both of these individuals on managing meaningful clinical outcomes 
personalized to each patient.  
 
 
  
 
Appendices 
  
 
  
 
Appendix 1: Diabetes Study How--‐To  
 
Current patients who have had a Diabetes Miletus (ICD 0250) diagnosis will have had the 
Flowchart added to their CPP. All that needs to happen now is loading the Templates and 
Profiles when the patient is in for the follow-­­up appointments.  
 
To add the Diabetes Study and flowchart for newly diagnosed patients and send them for their 
first diabetic panel:  
 
1.   Start the Encounter as usual.   
2.   Click on the “Profile” button at the top left of the Encounter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
  
 
 
3. In the Webpage Dialog window that opens, change the Master Profiles For: to Dr. John 
Campbell. 
 
  
 
4.   In the profiles list, click the box at the right of the Diabetes Study I – Visit I (or whichever 
visit this is) profile to put a checkmark in it and then click on the LOAD button at the top 
left of the page. This will load the profile and automatically input the Diagnosis, 
Consultations, Labs and Plan Notes into the Encounter. 
 
  
 
5.   Next, click on the LOAD TEMPLATE button at the top left of the page. 
 
  
 
6.   In the Webpage Dialog window that opens: (a.) change the View: drop down from 
Provider Templates to Enterprise Templates (b.) click on the checkbox next to *Diabetes 
Study to put a check mark in it (c.) then click the LOAD button. 
 
 
 
 
a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
c. 
 
 
 
 
 
 
 
b 
 
  
 
(d.) The template will load and allow entry of data. 
 
 
 
 
 
 
  
 
1.   Fill in all the applicable sections, scroll down or tab into the check and text boxes. When 
finished, click on the “SAVE” button to save the template into the Encounter. Whatever 
is filled in will be placed into the Encounter. 
 
 
 
2.   There are three Consults associated with the first Diabetic session. One for Fundoscopic 
exam, one for Diabetes Education and one for Diabetes Nutritional Education. You must 
open each one and assign the Consultant and adjust the preset text to reflect your 
current patient. 
3.   There is a Laboratory Requisition associated with this session, and all that is required is 
asign and print. 
 
  
 
4.   The Plan Notes are filled in generically, so you need to adjust the text to reflect the 
current status of your patient. 
 
 
 
 
 
 
 
 
 
5.   Once everything has been properly filled in, printed, signed and given to the patient, 
close the encounter in your preferred way. 
 
  
 
(5 
6.   The data will be collected by the Flowsheet created for this template. In 
order to activate the flowchart open the patient's CPP and click on the 
Flowsheet link: 
 
 
 
 
Patients -Nightingale On Demand - WEB06Q Philip LeBlanc -Windows Internet Explorer GJ[g][gl 
-------------------------------------------------------------------------------------------------------------------- 
Registration Details  Encounter Orders  Reports CPP  COM Setup Help 
A ; htingale. 
 
T raining,... 
Default C... 
Dummy Patient (F, 1960/ 1/1-53 years-A ct 
ve)(PA) 
#: 70 22;  Last Vi si t:Jun 10, 2013 
 
 
IOPTIONS j I 
Dl!shboard View  Cumulative Patient Profile Last Modified  on  Jun 27, 2012 at 12:26 PM 
 
chedule 
 
.E.atients 
 
!!.illing 
 
Allergi es 
Immunizations 
Consultations 
 
Probl em List 
Family Historv 
Lab Results 
l owsheets 
 
Med cations 
SocialHi story 
Al erts 
 
Injec t ons 
Procedures 
Past Med calH story 
 
Office 
Actions 
 
 
 
DRUG ALLERGY 
 
 
TYPE  STATUS  REACTION SEVERITY  COMMENT 
 
Review Not Done 
NON-DRUG ALLERGY 
 
,Enterprise r DRUG  INTOLERANCE 
 
Review Not Done 
Data Miner 
 
r NON-DRUG INTOLERANCE 
Review Not Done 
 
Review Not Done 
Problem List  
There are no problem list items in the patient's cumulative profile. 
 
 
 
Medications 
 
There are currently no  active medications for this patient. 
 
Loc]l. 
J:ogout  
Injections 
D I []  LIt 
 
  
 
7.   With the Flowsheet section heading highlighted in blue click on the Add button that will be in the 
menu at the top left: 
 
 
 
(5 Patients  -Nightingale On Demand - WEB06Q Philip LeBlanc -Windows Internet Explorer  [J[QJ[gj 
--------------------------------------------------------------------------------------------------------------------- 
Registration  Details Encounter  Orders  Reports CPP  COM Setup Help 
Aightinga/e. 
 
T raining,... 
Default C.•• 
Dummy Patient (F, 1960/1/ 1-53 years-A ct 
ve)(PA) 
#: 7022 ;   ast Vi si t:Jun 10, 2013 
 
 
ulative Patient Profile 
 
 
IOPTIONS j I 
last Modified  on Jun 27, 2012 at 12:26 PM 
 
 
 
 
Risk Assessment Tool 
 
Probl em List 
Family Historv 
Lab Results 
Flowsheets 
 
Medications 
Social History 
Al erts 
 
Injections 
Procedures 
Past Medical Hi story 
 
 
 
 
 
Reports 
 
,Enterprise 
Consultations 
 
 
Lab Results 
 
There are no consultations in the patient's cumulative profile. 
 
 
There are no  lab results in the patient's cumulative profile. 
 
Data Miner Alerts 
 
 
There are no  al erts in the patient's cumulati ve profile. 
 
Past MedicalHistory 
Past Medical History: 
dia betes, h yprercholesteremia 
 
Risk  Assessn1ent Tool 
 
CVO Calculator ResuIts: 
 
There are no risk assessment tool records. 
 
FlowSheets  
There are no flow  sheets in tl1e patient's cumulative patient profile. 
 
  
 
8.   a.) Choose the * Diabetes Study by clicking the check box and then the b.) Add button at 
the top left: 
 
 
 
 
 
 
 
 
 
 
b.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
a.) 
 
  
 
9.   The Flowsheet will open a window and collect the data that it is set to collect. Once it 
has completed collection, you may review the data by a.) sliding the slide bar down. 
When finished, click on the b.) Save button at the bottom of the window: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b.) 
 
  
 
10. Once saved, the options at the bottom change to Print, Save or Close. Choose 
whichever, but when done, choose the Close which will take you back to the CPP and 
will show the Flowsheet active in the patient’s CPP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11. All that is required now is to book the follow-­­up appointments. When the patient next 
comes in, load the next Template and Profile, and fill in the data. The Flowsheet will 
automatically update the data it is supposed to collect. 
 
The End 
 
  
 
  
 
Appendix 2: Logistic Regression Tables 
 
a. Dependent Variable: Whether A1c Was Measured according to Guidelines 
* There is a nul value in the table making measurement of Odd Ratio (OR) erroneous. 
 
b. Dependent Variable: Whether LDL was Measured According to Guidelines 
Variables in the Equation 
 Beta S.E. Wald df Sig. OR 
95% C.I.for OR 
Lower Upper 
Template Used 1.555 .501 9.650 1 .002 4.736 1.775 12.636 
Age .005 .015 .094 1 .760 1.005 .976 1.034 
Sex .726 .349 4.321 1 .038 2.066 1.042 4.095 
Number of Visits -.534 .352 2.299 1 .129 .586 .294 1.169 
Constant 1.053 1.016 1.075 1 .300 2.867   
 
c. Dependent Variable:  Whether BP was Measured According to Guidelines 
 
 
 
 
 
Variables in the Equation 
 Beta S.E. Wald df Sig. OR 
95% C.I.for OR 
Lower Upper 
Template Used* 17.944 3810.495 .000 1 .996 62096798.597 .000 . 
Age -.026 .036 .511 1 .475 .974 .907 1.046 
Sex -.890 .852 1.090 1 .296 .411 .077 2.182 
Number of Visits -.236 .813 .084 1 .772 .790 .160 3.887 
Constant 5.641 2.616 4.649 1 .031 281.715   
Variables in the Equation 
 B S.E. Wald df Sig. OR 
95% C.I.for OR 
Lower Upper 
Template Used .792 .347 5.201 1 .023 2.207 1.118 4.357 
Age .025 .013 3.907 1 .048 1.025 1.000 1.051 
Sex -.629 .298 4.451 1 .035 .533 .297 .956 
Number of Visits .201 .313 .412 1 .521 1.223 .662 2.257 
Constant -.192 .856 .050 1 .823 .825   
 
  
 
d. Dependent Variable: Whether HbA1c was at target at End of Study 
 
e. Dependent Variable: Whether LDL was at target at End of Study 
  
Variables in the Equation 
 B S.E. Wald df Sig. OR 
95% C.I.for OR 
Lower Upper 
Step 1a Template Used -.433 .350 1.532 1 .216 .649 .327 1.287 
Age -.026 .017 2.226 1 .136 .975 .942 1.008 
Sex -.303 .343 .783 1 .376 .738 .377 1.446 
Number of Visits -.821 .376 4.770 1 .029 .440 .211 .919 
Baseline A1c -2.663 .324 67.583 1 .000 .070 .037 .132 
Constant 21.047 2.634 63.862 1 .000 1382631855.181   
Variables in the Equation 
 B S.E. Wald Df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Template Used .772 .387 3.981 1 .046 2.165 1.014 4.623 
Age -.017 .017 .971 1 .324 .983 .951 1.017 
Sex .555 .375 2.188 1 .139 1.742 .835 3.633 
Number of Visits .434 .388 1.253 1 .263 1.544 .722 3.301 
Baseline LDL 3.526 .382 85.229 1 .000 33.986 16.077 71.846 
Constant -1.240 1.141 1.180 1 .277 .289   
 
  
 
 
 
  
 
 
f. Dependent Variable: Whether Systolic BP was at Target at End of Study 
 
Variables in the Equation 
 B S.E. Wald Df Sig. OR 
95% C.I.for OR 
Lower Upper 
Template Used -.279 .291 .918 1 .338 .757 .428 1.338 
Age -.032 .014 5.016 1 .025 .969 .943 .996 
Sex .079 .284 .077 1 .782 1.082 .620 1.888 
Number of Visits -.365 .303 1.453 1 .228 .694 .384 1.257 
Baseline systolic BP -.032 .011 8.699 1 .003 .969 .949 .989 
Constant 6.367 1.610 15.646 1 .000 582.279   
         
         
g. Dependent Variable: Whether Diastolic BP was at Target at End of Study 
 
 
Variables in the Equation 
 B S.E. Wald df Sig. OR 
95% C.I.for OR 
Lower Upper 
Template Used .309 .326 .900 1 .343 1.362 .719 2.580 
Age .011 .015 .553 1 .457 1.011 .982 1.040 
Sex .131 .309 .180 1 .671 1.140 .622 2.088 
Number of Visits -.209 .323 .419 1 .517 .811 .431 1.528 
Baseline Diastolic BP -.072 .021 12.157 1 .000 .931 .894 .969 
Constant 5.200 1.910 7.412 1 .006 181.334   
 
 
  
 
 
Appendix 3: Characteristics of Physicians 
 
 
a. Physicians using tool  
 
Sex Method of Remuneration Graduation Date 
Male Fee for service 2004 
Female Salary 2004 
Female Fee for service 2001 
 
 
b. Physicians not using tool 
 
Sex Method of remuneration Graduation Date 
Male Fee for service 2003 
Male Fee for service 2010 
Female Salary 2010 
Female Fee for service 2003 
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Course (APLS) for all family practice residents. 
 
Clinical Preceptor for CSAT program (2006-2013) with clinical teaching in the 
disciplines of family and emergency medicine.  
 
RESEARCH EXPERIENCE 
 
June 2010-2013 Sub-investigator on Tiosphere a randomized phase 
IIIb clinical trial relating to COPD management 
 
 
 
 
 
                                                                                                                                                                     
September 2008-2009 Principle author on an Obsevership Project for 
International Medical Graduates funded by Health 
Canada 
  
June 2007-November 2009 Lead Investigator Survey of Facilities Providing 
Emergency Care in Central Newfoundland 
conducted Central Health Care Authority 
 
March 2003-December 2003 Co-investigator Pain Management in Renal Colic, 
conducted in two emergency departments of the 
Health Care Corporation St. John’s  
 
August 2000 Summer studentship assisting in research of Dr. 
Michael Murray, Faculty of Medicine, Department 
of Community Medicine, Memorial University 
July 2000 Elective research, Dr. Jack Newman, Child and 
Adolescent Health Unit, Toronto, Ont. 
 
July & August 1999 Summer studentship assisting in research of Dr. 
Michael Murray, Faculty of Medicine, Department 
of Community Medicine, Memorial University 
 
PUBLICATIONS 
 
Campbell, J.A. When Things Go Wrong.  Canadian Family Physician. May 2005. 
 
Campbell, J.A. A Fresh Start. Canadian Family Physician. August 2003. 
 
Campbell, J.A. Thoughts on Residency. Canadian Family Physician. September 2003. 
 
Campbell, J.A. The College and You. Canadian Family Physician. April 2004 
 
PRESENTATIONS 
 
 
Campbell J.A., Privatization of Palliative Care, Prifor Dangerous Idea Soapbox, St. 
John’s July 2015. 
 
Campbell J.A., Evaluating Cognitive Error in Learners, Preceptor Meetings, Corner 
Brook 2013; St. John’s 2012. 
 
Campbell J.A., An Emergency Approach to CVA/TIA Assessment. Presented Fall 2012 
Wednesday @ Noon –Ask the Consultant Series October 2012. 
 
 
 
 
 
                                                                                                                                                                     
Campbell J.A., Executive Summary of Emergency Medicine Services in Central 
Newfoundland. Presented to Senior Executive Central Health Care Authority 
February 2009. 
 
Campbell J.A. Conceptualization of the Provision of Emergency Services in Central 
Health. Presented to Senior Executive Central Health Care Authority October 2007. 
 
Campbell J.A., Preparing Your Office for a Medical Emergency presented Family 
Practice Symposium July 2008 Terra Nova NL. 
 
Campbell J. A., and Halliday B. The Impact of Fifty Years of Family Medicine: Looking 
Forward-Looking Back The Hannah Lecture at FMF November 2004 Toronto ON. 
 
Campbell J.A., Induction of Labor Practices in Grand Falls Windsor and the SOGC 
Guidelines, Presented as Grand Rounds, October 2002 Grand Falls-Windsor, NF. 
 
Campbell J.A., and Sparrow S.M. The Use of Methadone in Palliative Care Pain 
Management, Presentation to the Palliative Care Physicians of Victoria, January 
2002 Victoria, BC. 
 
POSTERS 
 
Campbell J.A., T. Micks, E. Bautista, R. Brooks, H. Bruce, G. Higgins, K. Jim, T. 
Kabisios, J. Mercer, S. Parsons, S. Ralph, R. Ryan., Interdisciplinary Collaboration for 
Improved Maternal-Fetal Outcomes in Central Newfoundland. Poster Presentation at 
The Primary Healthcare Partnership Forum – St. John’s, NL June 2015. 
 
Campbell J.A., T. Micks, M. Sherman, L. Rourke., Resuscitating the Family Medicine 
Curriculum: A Novel Approach to Postgraduate Advanced Life Support skill Acquisition 
and Maintenance. Poster presentation SRPC April 2015 Vancouver, BC and The 
Primary Healthcare Partnership Forum – St. John’s, NL June 2015. 
 
Campbell J.A., Patti McCarthy, Bob Miller, Cheri Bethune, Ean Parsons, Marshall 
Godwin, Roger Butler, Leslie Rourke, Lyn Power, Sandy MacDonald, Madeline Cole, 
Lisa Grant, Reanne Meuse, Shannon Fisher., Docs on the Rocks: A Recipe for a Better 
Cocktail. Poster presentation SRPC 2013 Vancouver, BC 
 
Campbell J.A., Lynette Powell, Patti McCarthy, Kris Luscombe, Richard Lush, Colin 
Newman, Mark O’Driscoll, Steve Parsons, Leslie Rourke, Bob Miller, Interprofessional 
Teaching in a Rural Residency Teaching Site. Poster presentation SRPC 2013 
Vancouver, BC  
 
 
 
 
 
                                                                                                                                                                     
Campbell J.A. Killick Health Services and Family Medicine Education. Poster 
presentation FMF October 2010 Vancouver, BC 
 
Campbell J.A., Bannister E., Fleet L., Providing International Medical Graduates with 
Advanced Training and Support for Licensure. Poster presentation IEHP Atlantic 
Symposium, February 2010, Halifax, NS.  
 
Campbell J.A., Bannister E., Fleet L., Providing International Medical Graduates with 
Advanced Training and Support for Licensure. AMEE August/September 2009 
Malaga, Spain. 
 
Campbell J.A., and Campbell S.M.  A Comparison of IV Meperidine, Meperidine and 
Keterolac, and Fentanyl and Keterolac in ED Treatment of Renal Colic Pain, Resident’s 
Research Forum, March 2004 St. John’s NL.  
 
 
AWARDS AND CERTIFICATES 
 
Educational and Teaching Awards 
Gus Rowe Award, Memorial University (2015) 
Research Directors Award (2004) 
The Mary Honeygold Scholarship (2002) 
Medical Doctorate Memorial University Dean’s list (2002) 
BSC with Distinction, University of Victoria (1998) 
 
Professional Awards 
CFPC Early Career Development Award (2008) 
CFPC Family Medicine Resident Leadership Award (2003) 
 
Certificates 
Instructor: 
Neonatal Resuscitation Instructor (2014)  
Advanced Trauma Life Support Instructor (2012) 
Advanced Pediatric and Life Support Instructor and Course director (2009) 
Advanced Cardiac Life Support Instructors Course (2006) 
Provider 
Advanced Pediatric and Life Support (2009, 2005) 
Advanced Life Support Obstetrics (2009, 2004) 
Advanced Cardiac Life Support (2006, 2002) 
Pediatric Life Support Course (2005) 
Toxicology Road Show (2005) 
AIM (2005) 
NRP (2004) 
Advanced Trauma Life Support (2004) 
 
 
 
 
                                                                                                                                                                     
First Aid and Basic CPR Certificates (2000) 
 
Awards for Military Service 
United Nation’s Peace Keeping Medal Former Yugoslavia (1995) 
Special Service Force Ironman Competition (1991 & 1993) 
Persian Gulf War Service Medal (1991) 
Liberation of Kuwait Medal (1991) 
United Nation’s Peace Keeping Medal Cyprus (1989) 
 
 
POSITIONS HELD AND PROFESSIONAL AFFILIATIONS 
 
Current: 
Co-Chair Prehospital Care CNRHC (2015-Present) 
Regional Medical Advisor Paramedicine CNRHC (2015-Present) 
Newfoundland and Labrador College of Physicians and Surgeons Board Member 
(2010-Present) 
Member of Laboratory Interface Working Group EHR Project NLCHI (2010-Present) 
Member of Pharmacy Governance Advisory Board NLCHI (2010-Present) 
Member CPHSC (2010-Present) 
Member primary care research network (Sept 2009-Present) 
Canadian Association of Emergency Physicians (2004-Present) 
Canadian Medical Association (1998-Present) 
Newfoundland and Labrador Medical Association (1998-Present) 
Past: 
President Medical Staff CRNHC (2009- 2010) 
Peer to Peer Network NLCHI (2008-2009) 
Secretary Medical Staff CRNHC (2008 – 2009) 
Co-Chair Quality Initiatives Emergency Medicine Central West Health Care Board 
(2006-2013) 
Membership Advisory Committee National Chapter CFPC (2007- 2009) 
Member at Large Provincial Chapter CFPC (2006-2009) 
Palliative Care Committee (2005-2010) 
Chair of the Section of Residents for CFPC (2003-2004) 
Administrative Resident Family Medicine Program (2003-2004) 
Editorial Advisory Board for Canadian Family Physician (2002-2004) 
 
 
 
LEISURE ACTIVITIES 
 
The preparation and cooking of fine foods 
Applied automotive sciences in the restoration of a 1980 Camero 
 
 
 
 
                                                                                                                                                                     
 
 
VOLUNTEER EXPERIENCE 
 
Responsible sexuality project Organized project, revised manual and conducted 
training. (1999 and 2000) 
Palliative Care volunteers   Victoria Hospice, Victoria, BC (December 1997-
May 1998) 
 
 
 
 
